Apollomics Inc. (APLM) reporting calendar
Apollomics Inc. files periodic reports with the SEC as APLM on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 3 May 2026 – 27 Aug 2026
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 24 Apr 2026
- Reports on record
- 5
How this window is derived. Derived from this issuer's own filing history: 2 periods at a median 88-day cadence, filed a median 93 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open APLM market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 24 Apr 2026 | 114 days | 0001193125-26-177357 |
| 20-F | 31 Dec 2024 | 3 Apr 2025 | 93 days | 0000950170-25-050531 |
| 20-F | 31 Dec 2023 | 28 Mar 2024 | 88 days | 0000950170-24-038107 |
| 20-F | 29 Mar 2023 | 31 Mar 2023 | 2 days | 0001193125-23-088218 |
| 20-F | 31 Dec 2022 | 28 Apr 2023 | 118 days | 0001193125-23-127602 |
Source: SEC EDGAR company submissions for CIK 0001944885. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.